New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment - 10/15/2020 - 10/16/2020

New Approaches for an Integrated Nonclinical-Clinical QT/Proarrhythmic Risk Assessment

Source: FDA Center for Drug Evaluation and Research - What's New - September 15, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news